Quick Look Market Closing Price:
At the close: Dow +0.45% to 12560. S&P +0.65% to 1322. Nasdaq +0.63% to 2854.
Treasurys: 30-year -0.29%. 10-yr -0.14%. 5-yr -0.06%.
Commodities: Crude +0.15% to $79.33. Gold -0.89% to $1574.25.
Currencies: Euro -0.04% vs. dollar. Yen -0.21%. Pound -0.43%.
After Hours News:
Sealy Corporation (ZZ): FQ2 EPS of $0.03 beats by $0.02. Revenue of $312M (-2.9% Y/Y) in-line
H&R Block (HRB): FQ4 misses on a per share basis while coming in line with revenue expectations. Total revenue declined by 2.2% Y/Y however, due in large part to a previously announced strategic realignment and litigation expenses. Client share grew in both the assisted and digital categories, reaching a record 25.6M clients for the year. Shares +2.3% AH
Amicus Therapeutics (ERT) says it's achieved positive preliminary results from its ongoing phase 2 open-label drug-drug interaction study to evaluate the safety and effects of AT2220, co-administered with enzyme replacement therapy for Pompe disease. Shares -1.5% AH.
For the latest updates on the stock market, visit,